BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24890812)

  • 41. Management of Stage I cutaneous melanoma.
    Berdeaux DH; Moon TE; Meyskens FL
    Ariz Med; 1983 Nov; 40(11):768-72. PubMed ID: 6661064
    [No Abstract]   [Full Text] [Related]  

  • 42. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in sentinel lymph node-positive melanoma.
    Miranda EP
    J Clin Oncol; 2006 Nov; 24(32):5178; author reply 5178. PubMed ID: 17093288
    [No Abstract]   [Full Text] [Related]  

  • 43. An unexpected role for EGF in lymphangiogenesis-mediated melanoma metastasis to sentinel lymph nodes.
    Dadras SS
    J Invest Dermatol; 2013 Jan; 133(1):14-6. PubMed ID: 23299450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
    Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
    J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review and current perspectives of cutaneous malignant melanoma.
    Evans GR; Manson PN
    J Am Coll Surg; 1994 May; 178(5):523-40. PubMed ID: 8167894
    [No Abstract]   [Full Text] [Related]  

  • 46. Significance of serum S-100B in melanoma patients before and after sentinel node biopsy.
    Smit LH; Nieweg OE; Korse CM; Bonfrer JM; Kroon BB
    J Surg Oncol; 2005 May; 90(2):66-9; discussion 69-70. PubMed ID: 15844182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
    Špirić Z; Eri Ž; Erić M
    Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Malignant melanoma: conceptual and therapeutic innovations based on translational research].
    Piérard GE; Quatresooz P; Rorive A; Piérard-Franchimont C;
    Rev Med Liege; 2008 Oct; 63(10):579-84. PubMed ID: 19009964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients.
    Fujisawa Y; Otsuka F;
    Melanoma Res; 2012 Oct; 22(5):362-7. PubMed ID: 22713797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.
    McHugh JB; Su L; Griffith KA; Schwartz JL; Wong SL; Cimmino V; Chang AE; Johnson TM; Sabel MS
    Ann Surg Oncol; 2006 Sep; 13(9):1216-23. PubMed ID: 16952026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melanoma: workup and surveillance.
    Lifchez SD; Kelamis JA
    Clin Plast Surg; 2010 Jan; 37(1):55-63. PubMed ID: 19914458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Therapeutic and prognostic programming in cases of malignant melanoma].
    Veronesi U
    Schweiz Med Wochenschr; 1970 Jun; 100(23):976-81. PubMed ID: 5524713
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of sentinel lymph nodes positive for melanoma for features predictive of non-sentinel nodal disease and patient prognosis: a 49 patient series.
    Wright EH; Stanley PR; Roy A
    J Plast Reconstr Aesthet Surg; 2010 May; 63(5):e500-2. PubMed ID: 19800304
    [No Abstract]   [Full Text] [Related]  

  • 55. Current concepts on malignant melanoma.
    Das Gupta TK
    Surg Annu; 1970; 2(0):183-206. PubMed ID: 4950801
    [No Abstract]   [Full Text] [Related]  

  • 56. Insights into the mechanisms of lymph node metastasis.
    Nathanson SD
    Cancer; 2003 Jul; 98(2):413-23. PubMed ID: 12872364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma.
    Saltman BE; Ganly I; Patel SG; Coit DG; Brady MS; Wong RJ; Boyle JO; Singh B; Shaha AR; Shah JP; Kraus DH
    Head Neck; 2010 Dec; 32(12):1686-92. PubMed ID: 20848412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination.
    de Waal RM; van Altena MC; Erhard H; Weidle UH; Nooijen PT; Ruiter DJ
    Am J Pathol; 1997 Jun; 150(6):1951-7. PubMed ID: 9176389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.